Halozyme Therapeutics Inc banner

Halozyme Therapeutics Inc
SWB:RV7

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
SWB:RV7
Watchlist
Price: 54.82 EUR 0.15% Market Closed
Market Cap: €7.2B

Intrinsic Value

The intrinsic value for Halozyme Therapeutics Inc (RV7) under the Base Case is 86.52 EUR. Compared with the current market price of 54.82 EUR, the stock appears Undervalued by 37% .

RV7 Intrinsic Value
86.52 EUR
Undervaluation 37%
Intrinsic Value
Price €54.82
Bear Case
Base Case
Bull Case
Monitor RV7
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €69.22
Get notified when the price drops into your buy zone
Intrinsic Value €86.52
Margin of Safety 20% €69.22
Current Price €54.82
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about RV7?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is RV7 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Halozyme Therapeutics Inc.

Explain Valuation
Alternatives to RV7

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

HALO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RV7 stock?

The intrinsic value for Halozyme Therapeutics Inc (RV7) under the Base Case is 86.52 EUR.

Is RV7 stock undervalued or overvalued?

Compared with the current market price of 54.82 EUR, the stock appears Undervalued by 37% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett